HLN:LON
Haleon PLC
357,20 GBX
arrow_upward
+0,68%(+2,40) 1D
13. okt., 09.30.47 GMT+1 · GBX
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for HLN...
Åbn
358,40 GBX
Høj
360,90 GBX
Lav
355,50 GBX
Markedsværdi
31,44 mia.
Gns. vol.
32,06 mio.
Volumen
2,55 mio.
Udbytte
2,04 %
Kvartalsvis udbytte
1,82 GBX
Ex-dato
13. aug. 2026
P/E-forhold
19,71
Højeste i 52 uger
416,10 GBX
Laveste i 52 uger
317,80 GBX
Indtægt pr. aktie
0,18 GBX
Aktier i omløb
8,80 mia.
Antal ansatte
25 t
Åbn
358,40 GBX
Høj
360,90 GBX
Lav
355,50 GBX
Markedsværdi
31,44 mia.
Gns. vol.
32,06 mio.
Volumen
2,55 mio.
Udbytte
2,04 %
Kvartalsvis udbytte
1,82 GBX
Ex-dato
13. aug. 2026
P/E-forhold
19,71
Højeste i 52 uger
416,10 GBX
Laveste i 52 uger
317,80 GBX
Indtægt pr. aktie
0,18 GBX
Aktier i omløb
8,80 mia.
Antal ansatte
25 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
AskTraders.com
·
for 14 timer siden
Haleon Shares Rise for a Seventh Straight Session
Stock Traders Daily
·
for 23 timer siden
(HLN) and the Role of Price-Sensitive Allocations
Profil
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
Om Haleon PLC